Literature DB >> 15102503

Measurement of motor disability in MPTP-treated macaques using a telemetry system for estimating circadian motor activity.

C Barcia1, V De Pablos, V Bautista-Hernández, A Sanchez-Bahillo, A Fernández-Barreiro, M Poza, M T Herrero.   

Abstract

The parkinsonian symptoms of primates after MPTP exposure can be measured by several visual methods (classical motor scores). However, these methods have a subjective bias, especially as regards the evaluation of the motor activity. Computerized monitoring systems represent an unbiased method for measuring the motor disability of monkeys after MPTP administration. In this work the motor activity of monkeys before and after MPTP administration is measured and compared with the activity of a control intact group by means of a telemetry system. A pronounced decrease in motor activity was observed after MPTP administration. These results suggest the monitoring method used is suited for characterizing the motor incapacity and possible improvements following treatments to test different therapies to control Parkinson's disease in MPTP models involving primates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102503     DOI: 10.1016/j.jneumeth.2003.10.017

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  7 in total

1.  Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian.

Authors:  C Barcia; V Bautista; A Sánchez-Bahillo; E Fernández-Villalba; B Faucheux; M Poza y Poza; A Fernandez Barreiro; E C Hirsch; M-T Herrero
Journal:  J Neural Transm (Vienna)       Date:  2005-01-24       Impact factor: 3.575

Review 2.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

3.  A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson's disease.

Authors:  Akane Hayashi; Naoya Matsunaga; Hiroyuki Okazaki; Keisuke Kakimoto; Yoshinori Kimura; Hiroki Azuma; Eriko Ikeda; Takeshi Shiba; Mayumi Yamato; Ken-Ichi Yamada; Satoru Koyanagi; Shigehiro Ohdo
Journal:  Neuromolecular Med       Date:  2013-01-05       Impact factor: 3.843

4.  MarmoDetector: A novel 3D automated system for the quantitative assessment of marmoset behavior.

Authors:  Taiki Yabumoto; Fumiaki Yoshida; Hideaki Miyauchi; Kousuke Baba; Hiroshi Tsuda; Kensuke Ikenaka; Hideki Hayakawa; Nozomu Koyabu; Hiroki Hamanaka; Stella M Papa; Masayuki Hirata; Hideki Mochizuki
Journal:  J Neurosci Methods       Date:  2019-04-01       Impact factor: 2.390

5.  Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?

Authors:  Ana-Luisa Gil-Martínez; Lorena Cuenca; Consuelo Sánchez; Cristina Estrada; Emiliano Fernández-Villalba; María Trinidad Herrero
Journal:  J Neuroinflammation       Date:  2018-11-26       Impact factor: 8.322

Review 6.  Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease.

Authors:  Santiago Pérez-Lloret; Daniel P Cardinali
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

7.  Cardiac tyrosine hydroxylase activation and MB-COMT in dyskinetic monkeys.

Authors:  Lorena Cuenca-Bermejo; Pilar Almela; Pablo Gallo-Soljancic; José E Yuste; Vicente de Pablos; Víctor Bautista-Hernández; Emiliano Fernández-Villalba; María-Luisa Laorden; María-Trinidad Herrero
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.